Fresenius | FRE - Ebitda

Stock Price
43.58
Daily Change
-0.37 -0.84%
Monthly
-9.60%
Yearly
9.75%
Q2 Forecast
42.30

Fresenius reported EUR850M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Akzo Nobel EUR 385M 8M Sep/2025
Alcon AG USD 317M 337M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Beiersdorf EUR 984M 147M Jun/2025
DaVita Healthcare Partners USD 772.7M 89.45M Dec/2025
Demant DKK 2.76B 165M Dec/2025
E.ON EUR 1.78B 438M Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Getinge SEK 3.47B 2.13B Dec/2024
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GN Store Nord DKK 627M 106M Dec/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
RWE EUR 1.61B 274M Dec/2025
Sanofi EUR 4.84B 2.95B Sep/2025
Smith & Nephew USD 796M 139M Dec/2025